Browsing by Author "Djordjevic-DIkic, Ana (57003143600)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Prognostic value of stress echocardiography assessed by the ABCDE protocol(2021) ;Ciampi, Quirino (6602299243) ;Zagatina, Angela (22939399700) ;Cortigiani, Lauro (55663049600) ;Wierzbowska-Drabik, Karina (12772110800) ;Kasprzak, Jaroslaw D (35452933600) ;Haberka, MacIej (22834420800) ;Djordjevic-DIkic, Ana (57003143600) ;Beleslin, Branko (6701355424) ;Boshchenko, Alla (6602887127) ;Ryabova, Tamara (6701481228) ;Gaibazzi, Nicola (6603190525) ;Rigo, Fausto (6701803166) ;Dodi, Claudio (6602478787) ;Simova, Iana (23391267500) ;Samardjieva, Martina (57237410300) ;Barbieri, Andrea (56377673100) ;Morrone, Doralisa (36478990700) ;Lorenzoni, Valentina (57964799700) ;Prota, Costantina (55635036000) ;Villari, Bruno (6701632106) ;Antonini-Canterin, Francesco (36811810300) ;Pepi, Mauro (7006081973) ;Carpeggiani, Clara (7003751506) ;Pellikka, Patricia A (7007042258)Picano, Eugenio (7102408994)Aim: The aim of this study was to assess the prognostic value of ABCDE-SE in a prospective, large scale, multicentre, international, effectiveness study. Stress echocardiography (SE) was recently upgraded to the ABCDE protocol: step A, regional wall motion abnormalities; step B, B lines; step C, left ventricular contractile reserve; step D, Doppler-based coronary flow velocity reserve in left anterior descending coronary artery; and step E, electrocardiogram-based heart rate reserve. Methods and results: From July 2016 to November 2020, we enrolled 3574 all-comers (age 65 ± 11 years, 2070 males, 58%; ejection fraction 60 ± 10%) with known or suspected chronic coronary syndromes referred from 13 certified laboratories. All patients underwent clinically indicated ABCDE-SE. The employed stress modality was exercise (n = 952, with semi-supine bike, n = 887, or treadmill, n = 65 with adenosine for step D) or pharmacological stress (n = 2622, with vasodilator, n = 2151; or dobutamine, n = 471). SE response ranged from score 0 (all steps normal) to score 5 (all steps abnormal). All-cause death was the only endpoint. Rate of abnormal results was 16% for A, 30% for B, 36% for C, 28% for D, and 37% for E steps. During a median follow-up of 21 months (interquartile range: 13-36), 73 deaths occurred. Global X2 was 49.5 considering clinical variables, 50.7 after step A only (P = NS (not significant)) and 80.6 after B-E steps (P < 0.001 vs. step A). Annual mortality rate ranged from 0.4% person-year for score 0 up to 2.7% person-year for score 5. Conclusion: ABCDE-SE allows an effective prediction of survival in patients with chronic coronary syndromes. © 2021 The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.